Outcome of 561 non-metastatic triple negative breast cancer patients: Multi-center experience from Turkey

Budakoglu B., Altundag K., Aksoy S., Kaplan M. A., Ozdemir N. Y., Berk V., ...More

JOURNAL OF BUON, vol.19, no.4, pp.872-878, 2014 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 19 Issue: 4
  • Publication Date: 2014
  • Journal Name: JOURNAL OF BUON
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.872-878
  • Keywords: breast cancer, prognosis, treatment, triple negative, CHEMOTHERAPY, SUBTYPES, RECURRENCE, PATTERNS, TUMORS, TRIAL
  • Gazi University Affiliated: Yes


Purpose: Triple-negative breast cancers account for 15% of breast carcinomas and, when present as early-stage disease, they are associated with higher rates of recurrence and early distant metastasis risk when compared to hormone receptor positive and human epidermal growth factor receptor (HER-2) positive breast cancers. In this study we aimed to explore the basic clinicopathological characteristics, prognostic factors and recurrence patterns of non-metastatic triple negative breast cancer patients.